Oxaliplatin: all 947 studies that test it

Page 3 of 10. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.

• Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver MetastasesCompletedNCT01643070Phase 2Results posted
• Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the AppendixCompletedNCT01580410Phase 2Results posted
• Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the PancreasCompletedNCT01560949Phase 2Results posted
• Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric CancerCompletedNCT01515748Phase 3Results posted
• S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CancerCompletedNCT01498289Phase 2Results posted
• Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic DiseaseCompletedNCT01387295Phase 2Results posted
• CHFR Methylation Status Esophageal Cancer StudyTerminatedNCT01372202Phase 2Results posted
• FOLFIRINOX in Patients With Inoperable Pancreatic CancerTerminatedNCT01359007Phase 2Results posted
• Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate CancerCompletedNCT01338792Phase 2Results posted
• PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination ChemotherapyCompletedNCT01333033Phase 2Results posted
• Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder CancerCompletedNCT01308840Phase 2Results posted
• Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction CancerTerminatedNCT01307956Phase 2Results posted
• First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With RegorafenibCompletedNCT01289821Phase 2Results posted
• Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01280643Not applicableResults posted
• Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal CancerTerminatedNCT01279681Phase 3Results posted
• BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLCCompletedNCT01243775Phase 2Results posted
• Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater AdenocarcinomaCompletedNCT01208103Phase 2Results posted
• Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction CancerCompletedNCT01178944Phase 2Results posted
• A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.CompletedNCT01159171Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.CompletedNCT01135498Phase 2Results posted
• A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric CancerCompletedNCT01130337Phase 2Results posted
• Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube CancerActive, not recruitingNCT01081262Phase 3Results posted
• A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and AvastinCompletedNCT01077739Phase 2Results posted
• Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal CancerCompletedNCT01060007Phase 2Results posted
• A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract CancerTerminatedNCT00955721Phase 1/2Results posted
• Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00871169Phase 2Results posted
• A Study of IMC-1121B (Ramucirumab) in Colorectal CancerCompletedNCT00862784Phase 2Results posted
• Eloxatin® Plus Gemcitabine Chemotherapy for MesotheliomaCompletedNCT00859469Phase 2Results posted
• Exploratory Study Of The ERCC-1 GeneCompletedNCT00846482Not applicableResults posted
• Study of IMC-11F8 in Participants With Colorectal CancerCompletedNCT00835185Phase 2Results posted
• Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal CancerCompletedNCT00831181Phase 2Results posted
• Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal CancerCompletedNCT00828672Phase 2Results posted
• Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid TumorCompletedNCT00711243Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal CancerCompletedNCT00700570Phase 2Results posted
• S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal CancerCompletedNCT00686166Phase 2Results posted
• A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast CancerTerminatedNCT00674206Phase 2Results posted
• Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal AdenocarcinomaTerminatedNCT00667420Phase 1/2Results posted
• A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerTerminatedNCT00642603Phase 2Results posted
• CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaCompletedNCT00634751Phase 1/2Results posted
• Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal AdenocarcinomaTerminatedNCT00625183Phase 2Results posted
• A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal CancerCompletedNCT00623805Phase 3Results posted
• Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerCompletedNCT00613080Phase 2Results posted
• Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant ChemTerminatedNCT00612677Phase 2Results posted
• Perioperative Therapy for Resectable Pancreatic CancerCompletedNCT00609336Phase 2Results posted
• Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or StomachCompletedNCT00601705Phase 2Results posted
• Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerTerminatedNCT00591149Phase 2Results posted
• Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT00585078Phase 2Results posted
• Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal CancerCompletedNCT00578071Phase 1/2Results posted
• OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum.CompletedNCT00577031Phase 4Results posted
• Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric CancerCompletedNCT00555620Phase 1Results posted
• Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerTerminatedNCT00551759Phase 2Results posted
• Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryCompletedNCT00536874Phase 2Results posted
• Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction PatientsCompletedNCT00526110Phase 1/2Results posted
• Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal CarcinomaCompletedNCT00525915Phase 2Results posted
• Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)CompletedNCT00525785Phase 2Results posted
• Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) TumorsCompletedNCT00515216Phase 2Results posted
• Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerCompletedNCT00514020Phase 2Results posted
• Folfox-B Study for Patients With Colorectal Liver MetastasesTerminatedNCT00508872Phase 2Results posted
• Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck CancerCompletedNCT00503997Phase 2Results posted
• Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver CancerCompletedNCT00483405Phase 2Results posted
• Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)TerminatedNCT00480987Phase 1/2Results posted
• Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the UterusCompletedNCT00476086Phase 2Results posted
• Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and LeukemiasCompletedNCT00472849Phase 1/2Results posted
• Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal CancerCompletedNCT00470184Phase 2Results posted
• Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic CancerTerminatedNCT00463840Phase 1/2Results posted
• Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic CancerCompletedNCT00456599Phase 2Results posted
• Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLLCompletedNCT00452374Phase 1/2Results posted
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By SurgeryCompletedNCT00448760Phase 2Results posted
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Stage IV Gastric Cancer That Cannot Be Removed By SurgeryTerminatedNCT00448682Phase 2Results posted
• Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach CancerCompletedNCT00446290Phase 1Results posted
• Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal CancerCompletedNCT00444678Phase 2Results posted
• Chemotherapy for Participants With LymphomaCompletedNCT00436280Phase 2Results posted
• Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel CancerCompletedNCT00433550Phase 2Results posted
• Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal AdenocarcinomaTerminatedNCT00430027Not applicableResults posted
• Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian CarcinomaTerminatedNCT00418093Phase 2Results posted
• Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00416494Phase 2Results posted
• Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00408564Phase 2Results posted
• Study of XELOX With Cetuximab in Advanced Gastric CancerCompletedNCT00398398Phase 2Results posted
• Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine TumorsCompletedNCT00398320Phase 2Results posted
• Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor PatientsCompletedNCT00393861Phase 2Results posted
• Docetaxel and Oxaliplatin in Gastric CancerCompletedNCT00382720Phase 2Results posted
• Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder CancerCompletedNCT00361231Phase 2Results posted
• Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00356122Phase 2Results posted
• Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of VaterCompletedNCT00354887Phase 2Results posted
• Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach CancerTerminatedNCT00354224Phase 2Results posted
• A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.CompletedNCT00353262Phase 1Results posted
• Oxaliplatin and Capecitabine in Patients With Unresectable CholangiocarcinomaCompletedNCT00338988Phase 2Results posted
• Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer PatientsCompletedNCT00338039Phase 2Results posted
• Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL)CompletedNCT00336583Phase 2Results posted
• S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By SurgeryTerminatedNCT00335959Phase 2Results posted
• Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By SurgeryCompletedNCT00321828Phase 2Results posted
• Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal CancerCompletedNCT00321685Phase 2Results posted
• Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without BevacizumabTerminatedNCT00321100Phase 2Results posted
• Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the ColonTerminatedNCT00314353Phase 2Results posted
• Oxaliplatin and Topotecan in Advance Ovarian CancerTerminatedNCT00313612Phase 2Results posted
• Trastuzumab and Oxaliplatin in Patients With Metastatic Breast CancerCompletedNCT00297596Phase 2Results posted
• TEACO: Taxotere, Eloxatin, Avastin in Cancer of the OvaryCompletedNCT00296816Phase 2Results posted
• Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00290615Phase 2Results posted
• Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon CancerTerminatedNCT00276861Phase 2Results posted
• Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck MalignanciesCompletedNCT00266279Phase 2Results posted

← Oxaliplatin overview